scanX
Home
Novartis

Novartis

1,080.00
+8.75
(0.82%)
Market Cap (₹ Cr.)
₹2,645
52 Week High
1,248.00
Book Value
₹
52 Week Low
693.20
PE Ratio
30.26
PB Ratio
3.63
PE for Sector
41.08
PB for Sector
4.17
ROE
11.44 %
ROCE
55.09 %
Dividend Yield
2.33 %
EPS
₹36.72
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-9.16 %
Net Income Growth
-17.60 %
Cash Flow Change
153.13 %
ROE
-14.18 %
ROCE
43.73 %
EBITDA Margin (Avg.)
13.44 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
245
243
353
274
187
193
194
179
160
138
193
171
235
160
138
147
124
120
128
125
102
99
101
102
112
105
111
105
113
147
108
89
93
103
96
107
92
103
97
Expenses
190
222
213
194
153
162
160
157
151
127
152
144
147
142
124
122
91
115
121
108
83
88
86
97
84
90
97
92
142
89
85
73
67
73
62
65
70
68
69
EBITDA
54
21
141
80
34
31
35
22
9
11
41
26
88
19
14
25
33
6
7
16
19
11
16
5
28
14
14
13
-30
58
23
16
26
30
34
42
22
34
28
Operating Profit %
6 %
-3 %
1 %
-6 %
8 %
5 %
9 %
4 %
-4 %
-11 %
10 %
8 %
-17 %
-3 %
-16 %
10 %
18 %
-5 %
-2 %
8 %
12 %
5 %
11 %
-3 %
15 %
8 %
7 %
7 %
-45 %
26 %
16 %
10 %
12 %
19 %
21 %
23 %
14 %
26 %
21 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
3
3
4
3
3
3
3
3
3
3
1
1
1
1
2
2
1
0
0
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
5
2
0
0
0
1
2
2
2
2
2
2
3
2
2
2
0
1
1
1
0
1
1
0
0
0
0
Profit Before Tax
53
20
140
79
33
30
34
21
7
10
40
25
82
17
13
24
32
1
2
11
14
6
11
1
22
10
9
8
-31
57
21
14
23
28
32
41
21
34
28
Tax
1
7
36
21
12
11
12
9
5
3
14
9
54
7
5
11
11
1
1
7
7
2
4
4
13
4
3
3
-10
-2
5
5
-7
8
8
17
5
8
8
Net Profit
52
13
104
58
23
19
22
13
3
7
26
19
27
10
9
13
20
1
-5
8
7
4
8
-1
10
6
7
6
-23
52
18
8
25
20
24
27
15
26
20
EPS in ₹
16.25
4.17
32.45
18.28
7.14
5.97
7.03
4.77
1.03
2.50
9.28
6.66
9.60
4.05
3.80
5.21
7.91
0.32
-2.11
3.13
2.75
1.78
3.05
-0.29
3.93
2.55
2.84
2.57
-9.47
21.21
7.43
3.08
10.13
8.21
9.59
10.76
5.95
10.42
8.27
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,246
1,433
1,150
1,111
982
1,078
1,002
958
983
925
Fixed Assets
9
7
6
5
15
76
64
24
19
7
Current Assets
1,063
1,264
973
952
807
813
723
709
677
699
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
1,238
1,426
1,144
1,106
968
1,001
938
934
964
918
Total Liabilities
1,246
1,433
1,150
1,111
982
1,078
1,002
958
983
925
Current Liabilities
211
205
183
330
185
233
159
216
160
157
Non Current Liabilities
33
35
47
47
38
124
132
50
48
23
Total Equity
1,002
1,194
920
734
759
721
711
692
776
745
Reserve & Surplus
986
1,178
906
721
747
708
699
679
763
733
Share Capital
16
16
14
12
12
12
12
12
12
12
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
622
-613
51
-38
50
-9
-11
90
-139
26
Investing Activities
719
-631
424
69
274
56
95
87
-153
33
Operating Activities
-60
57
-41
161
-194
-23
-69
39
45
113
Financing Activities
-38
-39
-332
-268
-30
-41
-37
-36
-31
-121
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
70.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.32 %
0.19 %
0.19 %
0.19 %
0.19 %
DIIs
0.79 %
0.84 %
0.78 %
0.78 %
0.78 %
0.78 %
0.79 %
0.79 %
0.78 %
0.76 %
0.53 %
0.53 %
0.53 %
0.53 %
0.53 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.34 %
23.03 %
23.09 %
22.98 %
22.88 %
22.94 %
23.02 %
23.01 %
23.03 %
23.08 %
23.29 %
23.21 %
22.95 %
23.04 %
23.05 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,800.05 4,33,931.70 38.70 49,887.20 12.06 9,648 27.34 49.42
Cipla
1,533.90 1,21,755.80 26.38 26,520.70 14.17 4,155 12.95 51.95
Mankind Pharma
2,559.00 1,04,826.50 49.54 10,615.60 19.57 1,942 28.89 46.24
Dr Reddys Laboratories
1,224.50 1,01,936.60 19.09 28,905.40 12.36 5,578 -9.47 43.85
Zydus Life Science
982.10 98,062.50 22.93 19,831.50 13.82 3,831 14.57 51.51
Lupin
2,081.65 94,399.90 35.95 20,141.50 19.94 1,936 73.53 48.80
Aurobindo Pharma
1,264.30 72,876.10 20.17 29,559.20 17.55 3,169 8.66 38.95
Alkem Laboratories
5,637.35 68,065.40 31.30 12,978.40 9.84 1,812 14.16 47.37
Biocon
373.85 45,064.50 32.35 15,621.20 35.25 1,298 -84.31 67.11
Glenmark Pharmaceuticals
1,559.40 43,670.00 - 12,653.10 6.58 -1,831 675.49 46.46

Corporate Action

Technical Indicators

RSI(14)
Neutral
55.24
ATR(14)
Less Volatile
35.37
STOCH(9,6)
Neutral
71.84
STOCH RSI(14)
Overbought
84.28
MACD(12,26)
Bullish
5.00
ADX(14)
Weak Trend
13.30
UO(9)
Bearish
50.33
ROC(12)
Uptrend And Accelerating
2.37
WillR(14)
Neutral
-26.19
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Technical Screeners
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.